Moderna vaccine sales treble in first quarter

money profit income revenue
COVID-19 mRNA vaccine sends income and profits through the roof Vaccine sales for US biotech company Moderna were three times what they were for the same period last year, according to the company's just published first quarter 2022 results. This led the company, whose mRNA COVID-19 vaccine Spikevax was distributed exclusively by pharmacies on Australian

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous ‘Bizarre’ claims ‘yet another example of why the AMAQ can’t be trusted’: Guild
Next Pharmacists on alert over forged S8 scripts